ArticleFEMS yeast research2026
A refined Saccharomyces cerevisiae reference transcriptome from direct RNA sequencing, with a reusable pipeline for UTR annotation updates.
Article in FEMS yeast research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Untranslated regions (UTRs) flanking the coding sequence govern mRNA translation, localization, and decay, making accurate UTR boundaries essential for quantitative RNA sequencing and the study of post-transcriptional control. Reference transcriptomes built from short-read sequencing have been invaluable to the yeast community, yet in a genome as gene-dense as that of Saccharomyces cerevisiae, short reads cannot be assigned to a single transcript of origin, leaving roughly one quarter of transcripts without a defined UTR. Here, we use direct RNA sequencing (DRS), in which native polyadenylated molecules are sequenced without fragmentation or amplification, to reduce this ambiguity and deliver two complementary resources. First, an updated S. cerevisiae S288C reference: change-point segmentation of per-gene DRS coverage defined boundaries for 5682 of the 6607 genes in the backbone model, and a merge-max rule retaining the longer UTR from each source ensures no gene loses existing annotation. The result adds previously absent UTRs to 1213 (5') and 1220 (3') of the genes that the earlier short-read annotation left unannotated, and extends 28.9% of 5' and 19.4% of 3' boundaries among comparable genes. Second, the complete, documented pipeline so that the transcriptome can be rebuilt from any DRS data. Validation on two independent datasets shows improved mapping rates, reduced soft-clipping, and metagene profiles consistent with genuine transcript signal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.